Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Carcinoma, Renal Cell × Exercise × Clear all

Phase

Status

Terminated 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Motor Activity 9 Neoplasms 4 Breast Neoplasms 3 Weight Loss 1 Ventricular Dysfunction, Left 1 Urinary Incontinence 1 Sexual Dysfunction, Physiological 1 Sarcoma 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Polycystic Ovary Syndrome 1 Ovarian Neoplasms 1 Lymphoma 1 Leukemia 1 Insulin Resistance 1 Hypoxia 1 Hematologic Neoplasms 1 Heart Failure 1 Head and Neck Neoplasms 1 Fecal Incontinence 1 Fatigue 1 Cardiotoxicity 1 Carcinoma, Renal Cell 1 Brenner Tumor 1 Breast Diseases 1 Brain Neoplasms 1 Bone Metastases 1 Body Weight 1 Asthenia 1

Interventions

Nivolumab 20 Sunitinib 19 pembrolizumab 16 Sorafenib 15 Everolimus 12 Cyclophosphamide 11 Interleukin-2 10 Radiosurgery 8 Bevacizumab 8 pazopanib 7 spartalizumab 6 fludarabine 6 aldesleukin 6 Axitinib 6 Magnetic Resonance Spectroscopy 5 Ipilimumab 5 avelumab 4 Introns 4 peginterferon alfa-2b 3 cabozantinib 3 atezolizumab 3 Radiotherapy 3 Polymerase Chain Reaction 3 Nephrectomy 3 Irinotecan 3 Immunohistochemistry 3 Immunoglobulin G 3 Gene Expression Profiling 3 Gemcitabine 3 Cryosurgery 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03692338 2019-12-18

INTERVAL

Duke University

Phase NA Terminated

Carcinoma, Renal Cell, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡